A PYMNTS Company

US: Novartis animal unit buyout creates second-place leader

By  |  April 23, 2014

Eli Lilly-owned Elanco has inked a deal to acquire pharmaceutical giant Novartis’s Animal Health operations, a deal set to create the world’s second-largest animal health conglomerate.

The deal, estimated at $5.4 billion, was inked by the firms in an all-cash transaction, including debt.

Elanco president Jeff Simmons called the merger “the most transformational milestone” in the company’s history.

The deal will remain subject to regulatory clearance, say reports.

Full Content: Hoosier Ag Today

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.